Nexus Spine Announces Launch of Stable-C™ Cervical Interbody System with Integrated Fixation
Launch represents the company’s eighth commercial release within its line of Tranquil™ interbody fusion implants […]
Nomi Health Opens Infant and Pediatric COVID Vaccine Location
OREM, Utah–(BUSINESS WIRE)–Nomi Health, a direct healthcare company dedicated to improving access and lowering costs in the healthcare system, today opened their first location for infant and pediatric COVID vaccine services at West Valley City Centennial Park. To ensure the safest and most positive experience, each Nomi Health employee on site has completed extensive pediatric […]
Nomi Health Acquires Everyone Health, Sano Surgery
As Americans continue to pay more for needed medical treatments and with care costs outpacing the rate of inflation, Nomi Health — the direct healthcare company making it easier than ever to access the highest quality affordable care across the U.S.— today announced two acquisitions to bolster its support of buyers of care and their […]
Co-Diagnostics, Inc. Announces Shipment of Monkeypox Virus Test
Co-Diagnostics announced that it has shipped testing reagents for monkeypox virus currently exhibiting a multi-country outbreak to one of its international distributors. […]
Biomerics Launches Interventional Medical Plastics Division with Acquisition of Dependable Plastics
Biomerics announced the acquisition of Dependable Plastics and creation of a new division — Biomerics Interventional Medical Plastics (IMP) Division. […]
Senate Democrats Renew Plan for Drug Price Controls
Senate Democrats have renewed a push for drug pricing reforms, releasing on Wednesday proposed legislation along with a bill summary. […]
Sumitomo Pharma Oncology Receives Orphan Drug Designation for TP-3654, an Investigational Oral Inhibitor of PIM Kinases for the Treatment of Myelofibrosis
Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics, recently announced that the FDA granted Orphan Drug Designation for TP-3654, the company’s proprietary investigational oral inhibitor of PIM kinases, for the treatment of myelofibrosis. “This designation is an important milestone in the development of TP-3654 and highlights the need for potential new treatment […]
BD Names Rishi Grover as Chief Integrated Supply Chain Officer
FRANKLIN LAKES, N.J., July 5, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rishi Grover has been named executive vice president (EVP) and chief integrated supply chain officer for BD, effective July 7, 2022. In this role, Grover will have global responsibility for the […]
Sumitomo Pharma Oncology, Inc. Pursues Research and Discovery with Persistence – Featured in Pharma Tech Outlook
Sumitomo Pharma Oncology, Inc. (SMP Oncology) and Steve Warner, Ph.D., Senior Vice President and Head of US Research at SMP Oncology, were recently featured in a Pharma Tech Outlook. In “Sumitomo Pharma Oncology: Discovering Immunotherapy Agents with Persistence,” Dr. Warner discusses SMP Oncology’s ongoing work in immunotherapy drug discovery, highlighting the progress with the Company’s […]
Spectrum Wins Two Science & Technology Best of State Awards
Spectrum Solutions, LLC today announced it has been awarded two Utah Best of State Science & Technology Awards for Medical Innovation and Laboratory Equipment and Supplies. […]
$10k Women’s Seed Grant Announced at Inaugural BioHive Women’s Event
On June 24, BioHive held their inaugural Women’s event sponsored by BD, BioMerieux, e4H Architects, Health Catalyst, Known Medicine, MarshMcLennan, Recursion, Seek Labs and JLL Realty. With 180 registrants from 54 companies, attendees packed over 200 STEM Kits in partnership with Utah STEM Action Center for elementary and middle school students, listened to a panel […]
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
LONDON and SALT LAKE CITY, June 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the quarter ended March 31, 2022. Recent Highlights (including […]